If you’ve ever stared at a CT scan wondering why your beautifully packed anterior lumbar interbody fusion (ALIF) hasn’t fused — and resisted the urge to blame “the patient’s biology” yet again — this one’s for you.
A new retrospective cohort study dives into the world of lipids, statins, and fusion biology, asking a question no one really expected: Does your patient’s cholesterol level secretly dictate whether their ALIF will heal…or ghost you?
Subscribe to continue reading
- Unlimited access to our content and archive
- Exclusive access to our newsletter
- Join the Conversation! Exclusive access to article comments.
